Skip to main content
SpringerLink
Log in

Lippen-, Mundhöhlen- und Oropharynx-Tumoren

  • Chapter
Kompendium Internistische Onkologie

  • 12 Accesses

Zusammenfassung

Definition: Die Mundhöhle reicht von der Schleimhautgrenze der Lippe bis zum Übergang vom harten zum weichen Gaumen (obere Begrenzung) sowie bis zur Linie der Papillae vallatae. Der Oropharynx beinhaltet den Zungengrund, die Tonsillen und die Rachenhinterwand. Die Epiglottis gehört nach der neuesten UICC-Einteilung zur Supraglottis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahsee KW, Cooke TG, Pickford IR et al. (1994) An allelotype of sqamous carcinoma of the head and neck using microsatelite markers. Cancer Res 54: 1617–1621

    CAS  Google Scholar 

  • Ang KK, Peters LK, Maor MH, Morrison WH, Wendt CCD, Brown BW (1990) Concomitant boost radiotherapy schedules in in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19: 1339–1345

    Article  PubMed  CAS  Google Scholar 

  • Ang KK, Kaanders JHAM, Peters LJ (eds) (1994) Radiotherapy for head and neck cancers: indications and techniques. Lea amp; Febiger, Philadelphia

    Google Scholar 

  • Boyle JO, Hakim J, Koch W et al. (1993) The incidence of p53 mutations increases with progression of head and neck cancer. 53: 4477–4480

    CAS  Google Scholar 

  • Burkhardt A, Maerker R (1978) Dyplasieklassifikation oraler Leukoplakien und Präkanzerosen. Bedeutung für Prognose und Therapie. Dtsch Z Mund Kiefer Gesichtschir 2: 199

    Google Scholar 

  • Callender T, El-Nagger AK, Lee MS et al. (1994) PRAD-1 (CCBD 1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152–158

    Article  PubMed  CAS  Google Scholar 

  • Catimel G, Vermorken JB, Clavel M et al. (1994) A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 5: 533–537

    PubMed  CAS  Google Scholar 

  • Catimel G, Verweij J, Mattijssen V et al. (1994) Docetaxele (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 5: 533–537

    PubMed  CAS  Google Scholar 

  • Chicarilli ZN, Ariyan S (1987) Surgical management. In: Ariyan S (ed) Cancer of the head and neck. Mosby, St. Louis

    Google Scholar 

  • Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR (1992) Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 84: 793–796

    Article  PubMed  CAS  Google Scholar 

  • De Andrés L, Brunet J, Lopez-Pousa A et al. (1995) Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-MO head and neck cancer. J Clin Oncol 13: 1493–1500

    PubMed  Google Scholar 

  • Decker DA et al. (1983) Adjuvant chemotherapy with cis-diamminedichloroplatinum II and 1–2-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51: 1353–1355

    Article  PubMed  CAS  Google Scholar 

  • Foote RL, Parsons, JT, Mendenhall WM, Million RR, Cassisi NJ, Stringer ST (1990) Is interstitial implantation essential for successful radiotherapeutic treatment of base of tongue carcinoma? Int J Radiat Oncol Biol Phys 18: 1293–1298

    Article  PubMed  CAS  Google Scholar 

  • Forastiere AA (1991) Randomized trials of induction chemotherapy: A critical review. Hematol Oncol Clin North Am 5: 725–736

    PubMed  CAS  Google Scholar 

  • Forastiere AA, Urba SG (1995) Single agent paclitaxel and paclitaxel plus infosfamide in the treatment of head and neck cancer. Semin Oncol 22: 24–27

    PubMed  CAS  Google Scholar 

  • Forastiere AA, Metch B, Schuller DE et al. (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10: 1245–1251

    PubMed  CAS  Google Scholar 

  • Gebbia V, Testa A, Valenza R et al. (1993) A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 29A: 1358–1359

    Article  Google Scholar 

  • Gebbia V, Testa A, Valenza R et al. (1993) Vinorelbine plus cisplatin and 5fluorouracil in recurrent and/or metastatic squamous cell head and neck carcinoma. Proc Am Soc Clin Oncol 12: 283 (Abstr 917)

    Google Scholar 

  • Goffinet DR et al. (1975) Irradiation of clinically uninvolved cervical lymph nodes. Can J Otolaryngol 4: 927

    PubMed  CAS  Google Scholar 

  • Head and Neck Contracts Program (1987) Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report. Cancer 60: 301–311

    Article  Google Scholar 

  • Horiot JC, Le Fur R, N“Guyen T et al. (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25: 231–241

    Google Scholar 

  • Jacobs C, Makuch R (1990) Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8: 838–847

    PubMed  CAS  Google Scholar 

  • Jacobs C, Goffinet DR, Goffinet L et al. (1987) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60: 1178–1183

    Article  PubMed  CAS  Google Scholar 

  • Jacobs C, Lyman G, Valez-Garcia E et al. (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10: 257–263

    PubMed  CAS  Google Scholar 

  • Jarez P, Fernandez PL. Campo E et al. (1994) PRAD-1/Cyclin D1 gene amplification correlates with mesenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 4813–4817

    Google Scholar 

  • Kalniens IK et al. (1977) Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 134: 450

    Article  Google Scholar 

  • Keus RB, Pontvert D, Brunin F, Jaulerry Ch, Bataini JP (1988) Results of irradiation in squamous cell carcinoma of the soft palate and uvula. Radiother Oncol 11: 311–317

    Article  PubMed  CAS  Google Scholar 

  • Kristen K, Zöller J (1992) Tumoren im Kopf-und Halsbereich. In: Vinzenz K, Waclawiczek HW (Hrsg) Chirurgische Therapie von Kopf-Hals-Tumoren. Springer, Wien New York

    Google Scholar 

  • Laramore GE, Scott CB, Al-Sarraf M et al. (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study. Int J Radiat Oncol Biol Phys 23: 705–713

    Article  PubMed  CAS  Google Scholar 

  • Lefebvre JL, Sahmoud T, for the EORTC Head and Neck Cancer Cooperative Group (1994) Larynx preservation in hypopharynx squamous cell carcinoma: Peliminary results of a randomized study (EORTC 24891). Proc Am Soc Clin Oncol 13: 283 (Abstr 912)

    Google Scholar 

  • Leone LA et al (1968) Treatment of carcinoma of the head and neck with intravenous methotrexate. Cancer 21: 828–837

    Article  PubMed  CAS  Google Scholar 

  • Liverpool Head and Neck Oncology Group (1992) A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Br J Cancer 61: 311–315

    Google Scholar 

  • Lotan R, Xu XC, Lippman SM et al. (1995) Suppression of retinoic acid receptor-a in premaligmant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332: 1405–1410

    Article  PubMed  CAS  Google Scholar 

  • Mak-Kregar S, Hilgers FJM, Levendag PC et al. (1995) A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in the Netherlands. Eur Arch Otorhinopharyngol 252: 133–138

    CAS  Google Scholar 

  • Mashberg A, Meyers H (1976) Anatomical site and size of 222 early asymptomatic oral squamous carcinomas: A continuing prospective study of oral cancer. Cancer 37: 1149

    Article  Google Scholar 

  • Mazer TM, Robbins KT, Mc Murtrey MJ et al. (1988) Resection of pulmonary metastases from squamous carcinoma of the head and neck. Am J Surg 156: 238–242

    Article  PubMed  CAS  Google Scholar 

  • Merlano M, Grimaldi A, Benasso M et al. (1988) Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. Am J Clin Oncol 11: 538–542

    Article  PubMed  CAS  Google Scholar 

  • Merlano M, Corvo R, Marganno G et al. (1991) Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: The final report of randomized trial. Cancer 67: 915–921

    Article  PubMed  CAS  Google Scholar 

  • Merlano M, Vitale V, Rosso R et al. (1992) Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327: 1115–1121

    Article  PubMed  CAS  Google Scholar 

  • Million RR, Cassisi NJ (eds) (1994) Management of head and neck cancer, 2nd edn. Lippincott, Philadelphia

    Google Scholar 

  • Morton RP, Rugman F, Dorman EB et al. (1985) Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: A randomized factorial phase III controlled trial. Cancer Chemother Pharmacol 15: 282–289

    Article  Google Scholar 

  • Paccagnella A, Orlando A, Marcniori C et al. (1994) Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86: 265–272

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM et al. (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184

    Article  PubMed  CAS  Google Scholar 

  • Robert F, Wheller RH, Molthrop DC et al. (1994) Phase II study of topotecan in advanced head and neck cancer: Identification of an active new agent. Proc Am Soc Clin Oncol 13: 281 (Abstr 905)

    Google Scholar 

  • Rudert H (1992) Maligne Tumoren der Lippen, der Mundhöhle und des Oropharynx. In: Naumann HH et al. (Hrsg) Otorhinolaryngologie in Klinik und Praxis, Bd 2. Thieme, Stuttgart, S 648–668

    Google Scholar 

  • Schuller DE, Metch B, Stein DW et al. (1988) Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98: 1205–1211

    Article  PubMed  CAS  Google Scholar 

  • Shanmugaratnam K (1991) Histologic typing of tumours of the upper respiratory tract and ear, 2nd edn. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  • Shin DM, Kim J, Ro JY et al. (1994) Activation of p53 gene expression in pre-malignant lesions during head and neck tumorigenesis. Cancer Res 54: 321–326

    PubMed  CAS  Google Scholar 

  • Somers KD, Cartwright SL, Schechter GL (1990) Amplifications of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5: 915–920

    PubMed  CAS  Google Scholar 

  • Stevens KR Jr, Britsch A, Moss WT et al. (1993) High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29: 913

    Google Scholar 

  • The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685–1690

    Article  Google Scholar 

  • Van der Riet P, Nawroz H, Hruban RH et al. (1994) Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res 54: 1156–1158

    PubMed  Google Scholar 

  • Van Dyke DL, Worsham MJ, Benninger MS et al. (1994) Recurrent cytogenetic abnormalities in squamous cell carcinoma of the head and neck region. Genet Chromosom Cancer 9: 192–206

    Article  Google Scholar 

  • Veronesi A, Zagonel V, Tirelli U et al. (1985) High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: A randomized study. J Clin Oncol 3: 1105–1108

    PubMed  CAS  Google Scholar 

  • Verweij J, Alexiery-Figresch J, DeBoer MF (1988) Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group. Eur J Cancer Clin Oncol 24: 795–796

    Article  PubMed  CAS  Google Scholar 

  • Vokes EE (1993) Flourouracil modulation in head and neck cancer. In Rustum YM (ed) Novel approaches to selective treatments of human solid tumors: Laboratory and clinical correlation. Plenum Press, New York, pp 197–208

    Chapter  Google Scholar 

  • Vokes EE, Athanasiadis I (1996) Chemotherapy for squamous carcinoma of head and neck: The future is now. Ann Oncol 7: 15–29

    Article  PubMed  CAS  Google Scholar 

  • Vokes EE, Weichselbaum RR (1990) Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8: 911–934

    PubMed  CAS  Google Scholar 

  • Vokes EE, Rosenberg RK, Jahanzeb M et al. (1995) Multicenter phase II study of weekly oral vinorelbine for stage IV non-small cell lung cancer. J Clin Oncol 13: 637–644

    PubMed  CAS  Google Scholar 

  • Wang CC (1993) To reirradiate or not to reirradiate? Int J Radiat Oncol Biol Phys 29: 913

    Article  Google Scholar 

  • Wendt TG, Hartenstein RC, Wustrow TP et al. (1989) Cisplatin/fluorouracil with leucovorin enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: A phase II study. J Clin Oncol 7: 471–476

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Heermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Lenarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H.-J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heermann, R., Lenarz, T., Schmoll, HJ. (1997). Lippen-, Mundhöhlen- und Oropharynx-Tumoren. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation